228 related articles for article (PubMed ID: 31143932)
1. Device exchange from HeartMate II to HeartMate 3 left ventricular assist device.
Takeda K; Takayama H; Sanchez J; Cevasco M; Yuzefpolskaya M; Colombo PC; Naka Y
Interact Cardiovasc Thorac Surg; 2019 Sep; 29(3):430-433. PubMed ID: 31143932
[TBL] [Abstract][Full Text] [Related]
2. Late outcomes of subcostal exchange of the HeartMate II left ventricular assist device: a word of caution.
Yu SN; Takayama H; Han J; Garan AR; Kurlansky P; Yuzefpolskaya M; Colombo PC; Naka Y; Takeda K
Eur J Cardiothorac Surg; 2018 Oct; 54(4):652-656. PubMed ID: 29648627
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience with sternotomy versus subcostal approach for exchange of the HeartMate XVE to the HeartMate II ventricular assist device.
Gregoric ID; Bruckner BA; Jacob L; Kar B; Cohn WE; La Francesca S; Frazier OH
Ann Thorac Surg; 2008 May; 85(5):1646-9. PubMed ID: 18442556
[TBL] [Abstract][Full Text] [Related]
4. Do patients with the centrifugal flow HeartMate 3 or HeartWare left ventricular assist device have better outcomes compared to those with axial flow HeartMate II?
Florisson DS; Conte SM; De Bono JA; Newcomb AE
Interact Cardiovasc Thorac Surg; 2019 Dec; 29(6):844-851. PubMed ID: 31436825
[TBL] [Abstract][Full Text] [Related]
5. Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study.
Mehra MR; Salerno C; Cleveland JC; Pinney S; Yuzefpolskaya M; Milano CA; Itoh A; Goldstein DJ; Uriel N; Gulati S; Pagani FD; John R; Adamson R; Bogaev R; Thohan V; Chuang J; Sood P; Goates S; Silvestry SC
Circulation; 2018 Oct; 138(18):1923-1934. PubMed ID: 29807933
[TBL] [Abstract][Full Text] [Related]
6. Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure.
Uriel N; Colombo PC; Cleveland JC; Long JW; Salerno C; Goldstein DJ; Patel CB; Ewald GA; Tatooles AJ; Silvestry SC; John R; Caldeira C; Jeevanandam V; Boyle AJ; Sundareswaran KS; Sood P; Mehra MR
Circulation; 2017 May; 135(21):2003-2012. PubMed ID: 28385948
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study.
Colombo PC; Mehra MR; Goldstein DJ; Estep JD; Salerno C; Jorde UP; Cowger JA; Cleveland JC; Uriel N; Sayer G; Skipper ER; Downey FX; Ono M; Hooker R; Anyanwu AC; Givertz MM; Mahr C; Topuria I; Somo SI; Crandall DL; Horstmanshof DA
Circulation; 2019 Jan; 139(2):155-168. PubMed ID: 30586698
[TBL] [Abstract][Full Text] [Related]
8. HeartMate II Left Ventricular Assist Device Pump Exchange: A Single-Institution Experience.
Shaikh AF; Joseph SM; Lima B; Hall SA; Malyala R; Rafael AE; Gonzalez-Stawinski GV; Chamogeorgakis T
Thorac Cardiovasc Surg; 2017 Aug; 65(5):410-414. PubMed ID: 27903010
[No Abstract] [Full Text] [Related]
9. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
Goldstein DJ; Naka Y; Horstmanshof D; Ravichandran AK; Schroder J; Ransom J; Itoh A; Uriel N; Cleveland JC; Raval NY; Cogswell R; Suarez EE; Lowes BD; Kim G; Bonde P; Sheikh FH; Sood P; Farrar DJ; Mehra MR
JAMA Cardiol; 2020 Apr; 5(4):411-419. PubMed ID: 31939996
[TBL] [Abstract][Full Text] [Related]
10. Continuous-flow LVAD exchange to a different pump model: Systematic review and meta-analysis of the outcomes.
Austin MA; Maynes EJ; Gadda MN; O'Malley TJ; Morris RJ; Shah MK; Pirlamarla PR; Alvarez RJ; Entwistle JW; Massey HT; Tchantchaleishvili V
Artif Organs; 2021 Jul; 45(7):696-705. PubMed ID: 33350485
[TBL] [Abstract][Full Text] [Related]
11. Early Outcomes After Heart Transplantation in Recipients Bridged With a HeartMate 3 Device.
Suarez-Pierre A; Lui C; Zhou X; Crawford TC; Fraser CD; Giuliano K; Hsu S; Higgins RS; Zehr KJ; Whitman GJ; Choi CW; Kilic A
Ann Thorac Surg; 2019 Aug; 108(2):467-473. PubMed ID: 30880137
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular assist device exchange from HeartMate II to HeartMate 3 in an Asian patient-a case report and literature review.
Chang HH; Kuo TT; Chen PL; Kuo CC; Kuo CY; Wu NY
J Cardiothorac Surg; 2023 Mar; 18(1):82. PubMed ID: 36882839
[TBL] [Abstract][Full Text] [Related]
13. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
[TBL] [Abstract][Full Text] [Related]
14. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
[TBL] [Abstract][Full Text] [Related]
15. Use of left ventricular assist device (HeartMate II): a Singapore experience.
Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of modular cable exchange in HeartMate 3 patients versus conventional driveline repair in HeartMate II patients.
Merzah AS; Hanke JS; Li T; Saad Merzah FA; Gabriel M; Derda AA; Homann K; Haverich A; Schmitto JD; Dogan G
Artif Organs; 2023 Feb; 47(2):380-386. PubMed ID: 36148849
[TBL] [Abstract][Full Text] [Related]
17. De Novo Human Leukocyte Antigen Allosensitization in Heartmate 3 Versus Heartmate II Left Ventricular Assist Device Recipients.
Jain R; Habal MV; Clerkin KJ; Latif F; Restaino SW; Zorn E; Takeda K; Naka Y; Yuzefpolskaya M; Farr MA; Colombo PC; Sayer GT; Uriel N; Topkara VK
ASAIO J; 2022 Feb; 68(2):226-232. PubMed ID: 33883507
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular assist systems and infection-related outcomes: A comprehensive analysis of the MOMENTUM 3 trial.
Patel CB; Blue L; Cagliostro B; Bailey SH; Entwistle JW; John R; Thohan V; Cleveland JC; Goldstein DJ; Uriel N; Su X; Somo SI; Sood P; Mehra MR
J Heart Lung Transplant; 2020 Aug; 39(8):774-781. PubMed ID: 32276809
[TBL] [Abstract][Full Text] [Related]
19. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
20. First experiences with HeartMate 3 follow-up and adverse events.
Hanke JS; Dogan G; Rojas SV; Zoch A; Feldmann C; Deniz E; Avsar M; Warnecke G; Haverich A; Schmitto JD
J Thorac Cardiovasc Surg; 2017 Jul; 154(1):173-178. PubMed ID: 28268010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
